Fingerprint
Dive into the research topics of 'Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Ocrelizumab for the treatment of relapsing-remitting multiple sclerosis
Til Menge, Divyanshu Dubey, Clemens Warnke, Hans Peter Hartung, Olaf Stüve
Research output: Contribution to journal › Article › peer-review
12
Scopus
citations